Your browser doesn't support javascript.
loading
Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.
Barrio-Calvo, Marina; Kofoed, Søren Vester; Holste, Sofie Cens; Sørensen, Anders Bundgård; Viborg, Nadia; Kringelum, Jens Vindahl; Kleine-Kohlbrecher, Daniela; Steenmans, Christian Skjødt; Thygesen, Christian Bahne; Rønø, Birgitte; Friis, Stine.
Affiliation
  • Barrio-Calvo M; Evaxion Biotech, Hørsholm, Denmark.
  • Kofoed SV; Evaxion Biotech, Hørsholm, Denmark.
  • Holste SC; Evaxion Biotech, Hørsholm, Denmark.
  • Sørensen AB; Evaxion Biotech, Hørsholm, Denmark.
  • Viborg N; Evaxion Biotech, Hørsholm, Denmark.
  • Kringelum JV; Evaxion Biotech, Hørsholm, Denmark.
  • Kleine-Kohlbrecher D; Evaxion Biotech, Hørsholm, Denmark.
  • Steenmans CS; Evaxion Biotech, Hørsholm, Denmark.
  • Thygesen CB; Evaxion Biotech, Hørsholm, Denmark.
  • Rønø B; Evaxion Biotech, Hørsholm, Denmark.
  • Friis S; Evaxion Biotech, Hørsholm, Denmark.
Front Immunol ; 14: 1234912, 2023.
Article in En | MEDLINE | ID: mdl-37720215

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Vaccines, DNA / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Denmark Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Vaccines, DNA / Neoplasms Type of study: Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Denmark Country of publication: Switzerland